1
Return

Impact of the double deletion ΔG242-T243 in KPC-2 in the effectiveness of ceftazidime-avibactam and imipenem-relebactam

delete2025-06-04
delete0
delete
OA
AI
F
Florencia Brunetti
G
Gabriel Gutkind
L
Lin Gao
S
Shozeb Haider
R
Robert A. Bonomo
P
P.P. Power *
DOI:10.1128/aac.01915-24delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Combinations of beta-lactam-diazabicyclooctane inhibitors (DBOs) like ceftazidime-avibactam (CZA) and imipenem-relebactam (IMR) have shown efficacy in treating KPC-2-producing Klebsiella pneumoniae. However, CZA-resistant K. pneumoniae strains have been identified, often linked to substitutions and/or insertions/deletions in three different loops of KPC: (i) the Omega-loop region (amino acids 164-179), (ii) the 237-243 loop; and (iii) the 266-275 loop. This study investigates the impact of the double deletion Delta G242-T243 present in KPC-14. Our results demonstrate that the lower effectiveness of CZA against KPC-14 can be explained by both increased hydrolysis of ceftazidime and a lower affinity and acylation rate by avibactam. In contrast, the IMR combination was efficient in restoring susceptibility to the KPC-14 producing-clone. Although we also observed a lower affinity and acylation rate for relebactam in KPC-14, this reduction in affinity was accompanied by a loss in the carbapenemase activity, finally resulting in an IMR susceptibility phenotype for KPC-14. Expansion of the substrate profile of KPC-14 toward ceftazidime is associated with a trade-off for carbapenems, other penicillins, and cephalosporins, as well as a higher inhibition by clavulanic acid compared to KPC-2. This study provides a better understanding of how deletions in the 237-243 loop affect the effectiveness of novel DBO-combinations and supports the hypothesis that these mutations result in CZA resistance by other different biochemical mechanisms than mutations in the Omega-loop.
Keywords:
KPC-14
CZA
DBO
Klebsiella pneumoniae
avibactam
relebactam

Journal

Antimicrobial Agents and Chemotherapy cover
Antimicrobial Agents and Chemotherapy
IF:
4.5
Papers:
2.3W
Citations:
6.2W

Organization

U
UNIV BUENOS AIRES
Scholars:
465
Papers: 222
Citations: 52
L
louis stokes cleveland dept vet affairs med ctr
Scholars:
21
Papers: 7
Citations: 1
U
ucl sch pharm
Scholars:
21
Papers: 8
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers